Optimization of prostate cancer patient lymph node staging via the integration of neutrophil–lymphocyte ratios, platelet–lymphocyte ratios, and <sup>68</sup> Ga‐PSMA‐PET‐derived SUVmax values-Reference-Cited by-同舟云学术

Optimization of prostate cancer patient lymph node staging via the integration of neutrophil–lymphocyte ratios, platelet–lymphocyte ratios, and ⁶⁸ Ga‐PSMA‐PET‐derived SUVmax values

Published:2022-07-21 Issue:15 Volume:82 Page:1415-1421
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Wang Yinzhao,Tang Yongxiang¹,Gao Xiaomei²,Gan Yu³,Hu Shuo¹,Chen Min‐Feng³,Cai Yi³^ORCID

Affiliation:

1. Department of Nuclear Medicine, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University Changsha City Hunan Province China

2. Department of Pathology, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University Changsha City Hunan Province China

3. Department of Urology, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University Changsha City Hunan Province China

Funder

National Natural Science Foundation of China

Key Project of Research and Development Plan of Hunan Province

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24415

Reference39 articles.

1. Predicting Survival of Patients with Node-positive Prostate Cancer Following Multimodal Treatment

2. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial